Priority Date: 09.06.08 (EP 20080010458)

Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

  • Application ID: EP13176579
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB, Isenbruck Bösl Hörschler LLP and 192 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 09.06.2008 - Priority Date (EP 20080010458)
  • 15.01.2014 - Publication A1 (EP2684873)